Recommendations from the European Working Group for Value Assessment and Funding Processes in Rare Diseases (ORPH-VAL) by Annemans, Lieven, Aymé, Ségolène, Le Cam, Yann, Facey, Karen, Gunther, Penilla, Nicod, Elena, Reni, Michele, Roux, Jean-Louis, Schlander, Michael, Taylor, David, Tomino, Carlo, Torrent-Farnell, Josep, Upadhyaya, Sheela, Hutchings, Adam, Le Dez, Lugdivine

Get full text

Times of multiple crises: Reasons and ways to keep patient safety on the agenda by Cikkelova, Mirka, Gunther, Penilla, Boulanger, Stéphane

Get full text

ESOT Roadmap for Advanced Therapy Medicinal Products in Transplantation: Navigating Regulatory Challenges to Enhance Access and Care by Berishvili, Ekaterine, Piemonti, Lorenzo, de Koning, Eelco J P, Lindstedt, Sandra, Scholz, Hanne, Scott, William E, Auxenfans, Celine, Johnson, Paul, Martin, Dominique E, Gunther, Penilla, Mey, Devi, Potena, Luciano, Thaunat, Olivier

Get full text

Is Europe ready for xenotransplantation? by Kaiser, Matthias, Gunther, Penilla, Forsberg, Ellen-Marie, Mollaki, Vasiliki, Rimstad, Espen, Marusic, Ana

Get full text

Limitations of standard cost-effectiveness methods for health technology assessment of treatments for rare, chronic diseases: a case study of treatment for cystic fibrosis by Rubin, Jaime L., Lopez, Andrea, Booth, Jason, Gunther, Penilla, Jena, Anupam B.

Get full text

Limitations of standard cost-effectiveness methods for health technology assessment of treatments for rare, chronic diseases: a case study of treatment for cystic fibrosis by Rubin, Jaime L, Lopez, Andrea, Booth, Jason, Gunther, Penilla, Jena, Anupam B

Get full text